English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Dysregulated expression of Neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity.

MPS-Authors
/persons/resource/persons14877

Boretius,  S.
Biomedical NMR Research GmbH, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons41376

Steffens,  H.
Department of NanoBiophotonics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons45995

Berning,  S.
Department of NanoBiophotonics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons16030

Willig,  K. I.
Department of NanoBiophotonics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15082

Frahm,  J.
Biomedical NMR Research GmbH, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15210

Hell,  S. W.
Department of NanoBiophotonics, MPI for biophysical chemistry, Max Planck Society;

Fulltext (public)

2060629.pdf
(Publisher version), 4MB

2060629_Suppl_2.pdf
(Publisher version), 14MB

Supplementary Material (public)

2060629_Suppl_1.pdf
(Supplementary material), 10MB

Citation

Agarwal, A., Zhang, M., Trembak-Duff, I., Unterbarnscheidt, T., Radyushkin, K., Dibaj, P., et al. (2014). Dysregulated expression of Neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity. Cell Reports, 8(4), 1130-1145. doi:10.1016/j.celrep.2014.07.026.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0023-EC12-1
Abstract
Neuregulin-1 (NRG1) gene variants are associated with increased genetic risk for schizophrenia. It is unclear whether risk haplotypes cause elevated or decreased expression of NRG1 in the brains of schizophrenia patients, given that both findings have been reported from autopsy studies. To study NRG1 functions in vivo, we generated mouse mutants with reduced and elevated NRG1 levels and analyzed the impact on cortical functions. Loss of NRG1 from cortical projection neurons resulted in increased inhibitory neurotransmission, reduced synaptic plasticity, and hypoactivity. Neuronal overexpression of cysteine-rich domain (CRD)-NRG1, the major brain isoform, caused unbalanced excitatory-inhibitory neurotransmission, reduced synaptic plasticity, abnormal spine growth, altered steady-state levels of synaptic plasticity-related proteins, and impaired sensorimotor gating. We conclude that an “optimal” level of NRG1 signaling balances excitatory and inhibitory neurotransmission in the cortex. Our data provide a potential pathomechanism for impaired synaptic plasticity and suggest that human NRG1 risk haplotypes exert a gain-of-function effect.